Adverts

Open Access Articles- Top Results for Apricoxib

Apricoxib

</th></tr>
Apricoxib
File:Apricoxib structure.svg
Systematic (IUPAC) name
4-[2-(4-Ethoxyphenyl)-4-methyl-1H-pyrrol-1-yl]benzenesulfonamide
Clinical data
Identifiers
162011-90-7
PubChem CID 9820073
ChemSpider 7995822
Chemical data
Formula C19H20N2O3S
356.4387 g/mol

Apricoxib is an experimental anticancer drug in Phase II clinical trials. It is a COX-2 inhibitor which improves standard therapy response in molecularly defined models of pancreatic cancer.[1]

See also

References

  1. ^ Kirane, A. (2012). "Apricoxib, a Novel Inhibitor of COX-2, Markedly Improves Standard Therapy Response in Molecularly Defined Models of Pancreatic Cancer". Clinical Cancer Research 18 (18): 5031–5042. doi:10.1158/1078-0432.CCR-12-0453.  edit

Lua error in package.lua at line 80: module 'Module:Buffer' not found.